Intended for healthcare professionals
Search
Toggle navigation
Current issue
Archive
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Editorial board
For authors
Advertising
Contact us
News
Web Exclusives
Register
FREE
Sign in
×
Remember me
Not registered?
Forgot your password?
Comment: Continuing the learning curve
Neill Hepburn
I still feel nervous when asked to see neonates on the postnatal wards. Over 20 years ago, as a newly appointed Senior Registrar in Edinburgh, I was asked to come to see a newborn with blisters, on a Saturday afternoon. With thoughts of rare blistering conditions, such as epidermolysis bullosa (EB), on my mind, as I cycled into The Royal Infirmary of Edinburgh, I firmly counselled myself to remember more common conditions, such as bullous impetigo. When I saw the child I felt unsure, but, with more confidence than I felt, I took swabs for bacteriology and prescribed flucloxacillin. I promised to come back on Monday. You can imagine my consternation when the mother asked me if it might be EB!
Dermatology in practice
2012;
18
(2): 3–3
To continue reading this article, please
sign in
or
register
.
Follow us on
|
|
Latest News
Phase 3 trial results announced for melanoma treatment
Global atopic dermatitis awareness campaign launched
Promising results from phase 2 skin cancer trial
Dermavant’s Vtama shows promise in paediatric atopic dermatitis trial
Almirall’s lebrikizumab approved by EMA for atopic dermatitis
This site uses cookies in order to function properly and to allow us to improve our service. By using this site you consent to the use of cookies as set out in our
privacy policy